Search
for
Sort by
Research 451–480 of 1000+
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- Production of 5α-Reduced Neurosteroids Is Developmentally Regulated and Shapes GABA<sub>A</sub>Miniature IPSCs in Lamina II of the Spinal Cord
- Complications of Hair Transplant Procedures—Causes and Management
- Follikelhormone
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Harmless Herbs? A Review of the Recent Literature
- The Dynamics of the Skin’s Immune System
- Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Transforming growth factor-β in stem cells and tissue homeostasis
- Tracing the cellular origin of cancer
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Cutaneous complications of chemotherapeutic agents
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Lupus erythematosus: systemic and cutaneous manifestations
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- Folliculitis decalvans
- Interferon in the treatment of cutaneous T-cell lymphoma
- Nutrition and Hair
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Cutaneous lupus erythematosus
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Beyond Expectations